IVD Medical Holding Management

Management Kriterienprüfungen 2/4

IVD Medical Holding's CEO ist Kuk Sing Ho, ernannt in Jun 2019, hat eine Amtszeit von 4.92 Jahren. Die jährliche Gesamtvergütung beträgt CN¥3.70M, bestehend aus 99.8% Gehalt und 0.2% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 12.96% der Aktien des Unternehmens, im Wert von HK$207.11M. Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 4.9 Jahre bzw. 2.6 Jahre.

Wichtige Informationen

Kuk Sing Ho

Geschäftsführender

CN¥3.7m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	99.8%
Amtszeit als Geschäftsführer	5yrs
Eigentum des Geschäftsführers	13.0%
Durchschnittliche Amtszeit des Managements	5yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	2.7yrs

Jüngste Management Updates

Recent updates

Little Excitement Around IVD Medical Holding Limited's (HKG:1931) Earnings As Shares Take 38% Pounding

Jun 07

These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Safely

May 22

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 25

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 03

IVD Medical Holding Limited's (HKG:1931) 28% Price Boost Is Out Of Tune With Earnings

Mar 30

IVD Medical Holding (HKG:1931) Is Paying Out A Larger Dividend Than Last Year

Mar 20

If EPS Growth Is Important To You, IVD Medical Holding (HKG:1931) Presents An Opportunity

Mar 06

IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price

Feb 08

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 05

IVD Medical Holding (HKG:1931) Is Increasing Its Dividend To CN¥0.0556

Mar 22

Returns At IVD Medical Holding (HKG:1931) Are On The Way Up

Feb 16

Does IVD Medical Holding (HKG:1931) Have A Healthy Balance Sheet?

Oct 16

Calculating The Intrinsic Value Of IVD Medical Holding Limited (HKG:1931)

Sep 28

IVD Medical Holding (HKG:1931) Has A Rock Solid Balance Sheet

May 16

IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To HK$0.053

Apr 14

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 23

IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price

Mar 16

IVD Medical Holding (HKG:1931) Is Experiencing Growth In Returns On Capital

Jul 30

These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Reasonably Well

May 04

There's Been No Shortage Of Growth Recently For IVD Medical Holding's (HKG:1931) Returns On Capital

Apr 20

IVD Medical Holding's (HKG:1931) Stock Price Has Reduced 44% In The Past Year

Mar 05

Are IVD Medical Holding's (HKG:1931) Statutory Earnings A Good Guide To Its Underlying Profitability?

Feb 15

Here's What IVD Medical Holding Limited's (HKG:1931) Shareholder Ownership Structure Looks Like

Jan 31

A Look At The Fair Value Of IVD Medical Holding Limited (HKG:1931)

Jan 16

Does IVD Medical Holding (HKG:1931) Have The Makings Of A Multi-Bagger?

Jan 01

How Does IVD Medical Holding Limited (HKG:1931) Fare As A Dividend Stock?

Dec 17

Have Insiders Been Buying IVD Medical Holding Limited (HKG:1931) Shares This Year?

Dec 02

IVD Medical Holding's(HKG:1931) Share Price Is Down 28% Over The Past Year.

Nov 19

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Kuk Sing Ho im Vergleich zu den Einnahmen von IVD Medical Holding verändert?
Datum	Gesamtvergütung	Gehalt	Unternehmensgewinne
Dec 31 2023	CN¥4m	CN¥4m	CN¥238m
Sep 30 2023	n/a	n/a	CN¥235m
Jun 30 2023	n/a	n/a	CN¥232m
Mar 31 2023	n/a	n/a	CN¥221m
Dec 31 2022	CN¥5m	CN¥4m	CN¥210m
Sep 30 2022	n/a	n/a	CN¥193m
Jun 30 2022	n/a	n/a	CN¥177m
Mar 31 2022	n/a	n/a	CN¥176m
Dec 31 2021	CN¥4m	CN¥4m	CN¥175m

Vergütung im Vergleich zum Markt: Kuk SingDie Gesamtvergütung ($USD510.85K) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt Hong Kong ($USD349.42K).

Entschädigung vs. Einkommen: Kuk SingDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.

Geschäftsführer

Kuk Sing Ho (64 yo)

5yrs

Amtszeit

CN¥3,700,000

Vergütung

Mr. Ho Kuk Sing serves as Executive Director, Chairman of the Board and Chief Executive Officer at IVD Medical Holding Limited since June 21, 2019. He was Director of IVD Medical Holding Limited since May...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Kuk Sing Ho	Chairman & CEO	5yrs	CN¥3.70m	12.96% CN¥ 138.7m
Xianya Lin	GM & Executive Director	5yrs	CN¥2.16m	8.32% CN¥ 89.0m
Kim Fai Law	CFO, Joint Company Secretary & Executive Director	less than a year	keine Daten	keine Daten
Siu Kei Ken Chan	Executive Director	less than a year	keine Daten	keine Daten
Bo Yang	Financial Controller	8.3yrs	keine Daten	keine Daten
Wai Yan Lam	Company Secretary	no data	keine Daten	keine Daten

5.0yrs

Durchschnittliche Betriebszugehörigkeit

47yo

Durchschnittliches Alter

Erfahrenes Management: Das Managementteam von 1931 ist erfahren und erfahren (durchschnittliche Amtszeit: 5 Jahre).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Kuk Sing Ho	Chairman & CEO	8.1yrs	CN¥3.70m	12.96% CN¥ 138.7m
Xianya Lin	GM & Executive Director	8.4yrs	CN¥2.16m	8.32% CN¥ 89.0m
Kim Fai Law	CFO, Joint Company Secretary & Executive Director	less than a year	keine Daten	keine Daten
Siu Kei Ken Chan	Executive Director	less than a year	keine Daten	keine Daten
Sze Lok Wong	Independent Non-Executive Director	less than a year	keine Daten	keine Daten
Renqian Zhong	Independent Non-Executive Director	5yrs	CN¥120.00k	keine Daten
Ka Sing Leung	Independent Non-Executive Director	5yrs	CN¥120.00k	keine Daten
Haiyun Yao	Non-Executive Director	2.7yrs	keine Daten	keine Daten
Fei Liu	Non-executive Director	less than a year	keine Daten	keine Daten

2.7yrs

Durchschnittliche Betriebszugehörigkeit

51yo

Durchschnittliches Alter

Erfahrener Vorstand: 1931Die Vorstandsmitglieder gelten nicht als erfahren ( 2.6 Jahre durchschnittliche Amtszeit), was auf einen neuen Vorstand hindeutet.

IVD Medical Holding Management

Management Kriterienprüfungen 2/4

Wichtige Informationen

Jüngste Management Updates

IVD Medical Holding Limited Appoints Law Kim Fai as Chief Financial Officer

IVD Medical Holding Limited, Annual General Meeting, May 16, 2024

IVD Medical Holding Limited Announces Executive Changes

IVD Medical Holding Limited Announces Resignation of Sun Tao as a Non-Executive Director

IVD Medical Holding Limited Announces Board Changes

Less than half of directors are independent

Recent updates

Investor sentiment deteriorates as stock falls 17%

Little Excitement Around IVD Medical Holding Limited's (HKG:1931) Earnings As Shares Take 38% Pounding

New major risk - Share price stability

These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Safely

Investor sentiment deteriorates as stock falls 16%

Investor sentiment deteriorates as stock falls 17%

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

New minor risk - Share price stability

IVD Medical Holding Limited's (HKG:1931) 28% Price Boost Is Out Of Tune With Earnings

IVD Medical Holding Limited Appoints Law Kim Fai as Chief Financial Officer

Investor sentiment improves as stock rises 15%

IVD Medical Holding (HKG:1931) Is Paying Out A Larger Dividend Than Last Year

Full year 2023 earnings released: EPS: CN¥0.18 (vs CN¥0.16 in FY 2022)

IVD Medical Holding Limited, Annual General Meeting, May 16, 2024

IVD Medical Holding Limited Announces Executive Changes

If EPS Growth Is Important To You, IVD Medical Holding (HKG:1931) Presents An Opportunity

IVD Medical Holding Limited to Report Q4, 2023 Results on Mar 15, 2024

Investor sentiment improves as stock rises 25%

IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price

IVD Medical Holding Limited Announces Resignation of Sun Tao as a Non-Executive Director

Calculating The Fair Value Of IVD Medical Holding Limited (HKG:1931)

Investor sentiment improves as stock rises 16%

Now 25% undervalued

IVD Medical Holding's (HKG:1931) Returns On Capital Are Heading Higher

Investor sentiment improves as stock rises 22%

Upcoming dividend of HK$0.03 per share at 7.1% yield

IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To CN¥0.0297

IVD Medical Holding Limited Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on September 13, 2023

First half 2023 earnings released: EPS: CN¥0.076 (vs CN¥0.061 in 1H 2022)

IVD Medical Holding Limited Declares the Payment of an Interim Dividend for the Six Months Ended 30 June 2023, Expected to Be Paid on 6 September 2023

IVD Medical Holding Limited Announces Board Changes

IVD Medical Holding Limited to Report First Half, 2023 Results on Aug 18, 2023

Upcoming dividend of HK$0.056 per share at 5.2% yield

Investor sentiment improves as stock rises 15%

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

IVD Medical Holding (HKG:1931) Is Increasing Its Dividend To CN¥0.0556

Full year 2022 earnings released: EPS: CN¥0.16 (vs CN¥0.13 in FY 2021)

Investor sentiment deteriorates as stock falls 20%

Now 21% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 20%

Returns At IVD Medical Holding (HKG:1931) Are On The Way Up

Less than half of directors are independent

Does IVD Medical Holding (HKG:1931) Have A Healthy Balance Sheet?

Investor sentiment deteriorated over the past week

Calculating The Intrinsic Value Of IVD Medical Holding Limited (HKG:1931)

Upcoming dividend of HK$0.027 per share

IVD Medical Holding Limited Declares Interim Dividend for the Six Months Ended June 30, 2022, Payable on 19 September 2022

First half 2022 earnings released: EPS: CN¥0.061 (vs CN¥0.06 in 1H 2021)

Investor sentiment improved over the past week

Upcoming dividend of HK$0.053 per share

IVD Medical Holding (HKG:1931) Has A Rock Solid Balance Sheet

Less than half of directors are independent

IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To HK$0.053

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

IVD Medical Holding Limited, Annual General Meeting, May 20, 2022

IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price

Upcoming dividend of HK$0.027 per share

First half 2021 earnings released: EPS CN¥0.06 (vs CN¥0.029 in 1H 2020)

First half 2021 earnings released: EPS CN¥0.06 (vs CN¥0.029 in 1H 2020)

IVD Medical Holding (HKG:1931) Is Experiencing Growth In Returns On Capital

IVD Medical Holding Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2021

IVD Medical Holding Limited Approves Final Dividend for the Year Ended 31 December 2020

Upcoming dividend of HK$0.036 per share

These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Reasonably Well

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥0.12 (vs CN¥0.24 in FY 2019)

There's Been No Shortage Of Growth Recently For IVD Medical Holding's (HKG:1931) Returns On Capital

IVD Medical Holding Limited Recommends the Payment of a Final Dividend for the Year Ended 31 December 2020, Payable on or Around 2 July 2021